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Summary 
Our understanding of thymocyte development and of the positive and negative selection events 
involved in shaping the repertoire of mature T lymphocytes has been greatly facilitated by the 
use of transgenic and gene knockout animals. Much less is known about the factors that control 
the homing and population of the thymus by T cell precursors and the subsequent migration 
of developing thymocytes  through the thymic architecture. As the integrins represent a candidate 
group of cell surface receptors that may regulate thymocyte development, we have analyzed the 
expression and function of oe4fll and c~5fll on human thymocytes. A major portion of double 
positive (CD4+CD8 +) human thymocytes express oe4fll in a constitutively active form and 
adhere to fibronectin and vascular cell adhesion molecule 1. ot4fll expression is similar on adherent 
and nonadherent populations, thus, activity reflects the receptor state and not simple expression. 
The adherent cells are immature, expressing high levels of CD4/CD8 and low levels of CD3 
and CD69.  In contrast,  nonadherent cells possess the phenotype of thymocytes after positive 
selection, expressing intermediate levels of CD4 and/or CD8 and high levels of CD3 and CD69. 
The adherent population  fails to respond to activation with anti-CD3 and fibronectin, whereas 
nonadherents exhibit an r  proliferation. Differential regulation of oe4fll and oe5fll 
receptors may provide a mechanism controlling cellular traffic, differentiation, and positive selection 
of thymocytes. 
T 
he normal development of mature T  lymphocytes re- 
quires the successful completion of a complex matura- 
tion process that begins with CD4-CD8-CD3-  cells in the 
thymus (1-4). These precursors rearrange their TCR genes 
and express low levels of TCK-cx/fl with the CD3 complex, 
CD4 and CD8 (5,  6).  The next stage of development in- 
volves positive selection of those CD4 +  CD8 + double posi- 
tive (DP) 1 cells which express TCR capable of recognizing 
antigens in the context of self-MHC molecules. Positive se- 
lection of DPs expressing MHC class II-restricted TCRs in- 
volves an  accessory signal delivered by CD4  engagement 
whereas selection of class I-restricted TCRs involves CD8 
(7). Although a large fraction of the DPs die without under- 
1 Abbreviations  used in thispaper: AD, adherent,  DN, double  negative;  DE 
double positive; ECM, extracellular  matrix; FN, fibronectin; ICAM, 
intercellular  adhesion  molecule;  MFI, mean  fluorescence  intensity;  NAD, 
nonadherent; SP, single positive; UNS, unseparated;  VCAM-1, vascular 
cell adhesion molecule  1. 
going positive selection, when positive selection is successful, 
the DPs increase their expression of the TCK/CD3 complex, 
the CD69 antigen (8, 9), and progressively decrease either 
CD4 or CD8 (10, 11). Subsequently, negative selection results 
in the deletion  of autoreactive thymocytes (12). Although 
T cell maturation in the thymus can be followed by changes 
in the expression of multiple cell surface antigens,  surpris- 
ingly little is known about the factors that control the homing 
and population  of the thymus by T cell precursors and the 
subsequent migration of developing thymocytes  through the 
thymic architecture  from cortex to medulla during which 
the critical signals for selection and maturation are delivered. 
It is likely that these events are regulated at different stages 
of thymocyte development by manipulating the activity of 
specifc cell surface receptors. In turn, these receptors direct 
and facilitate  thymocyte  interactions with various components 
of the thymic stroma including cortical and medullary epi- 
thelium, antigen presenting or dendritic cells, and the ex- 
tracellular matrix (ECM)  proteins  of the interstitium. 
One candidate group of cell surface  receptors that may con- 
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of heterodimers constructed from noncovalendy associated 
pairs of at least eight distinct/5 chains and 14 ot chains (13). 
Thymocytes express the/51 chain integrins, a4/51 and c~6B1 
(14-16), sometimes referred to as very late antigens (VLAs) 
4 and 6, and the/51 chain integrin receptors mediate adhe- 
sion and directed movement of peripheral blood T lympho- 
cytes on extracellular  matrix proteins  including collagen, 
fibronectin (FN), and laminin (16, 17). Specifically,  ot4/31 is 
a receptor for FN and ot6/51 is a receptor for laminin (16, 
18-20).  Moreover, ol4/51 can bind to vascular cell adhesion 
molecule 1 (VCAM-1), a member of the Ig gene superfamily 
(21-22).  Thymocytes also uniformly express high levels of 
the leukocyte-specific/52 chain integrin, aL/52 (15, 16, 23), 
often called LFA-1. The ligands for o~L/52 are integral mem- 
brane proteins of the Ig gene superfamily intercellular adhe- 
sion molecules (ICAM) 1, 2, and 3 (13). ICAM-1 is expressed 
by thymic epithelial cells and its expression can be upregu- 
lated by a number of inflammatory cytokines (e.g. IL-1, TNF, 
and IFN-3,) (24). 
The function of the integrins  in cell-cell and cell-ECM 
interactions can be changed by regulating their level of cell 
surface expression (13, 25). However, cells can also modulate 
the binding properties of the integrins without changing their 
level of expression (17, 26). On T lymphocytes, c~L/52 is not 
constitutively avid for ICAM-1, but is converted to a high 
avidity state after cell activation by phorbol ester or by stim- 
ulation of the TCR (27). Similarly, cell activation is required 
to upregulate the activity of o~4~/1, ol5/51, and c~6/51 on resting 
mature peripheral T cells (20). A number of mechanisms have 
been identified that may control how an integrin is trans- 
formed from the resting to the activated state, including sig- 
naling via the cytoplasmic domains of the ct chains (28-30), 
phosphorylation (31-34), lipid factors (35, 36), glycosylation 
(37), and interaction with a novel intracellular signal-trans- 
ducing molecule (38). In contrast to these models of inte- 
grin activation  are model systems in which integrins  are 
reported  to  lose  activity  during  development  without  a 
significant decrease in cell surface expression (39, 40). The 
biochemical basis for integrin deactivation has not yet been 
defined. In addition to these examples  of  what has been termed 
"inside to out" signaling (13, 41), there is considerable evi- 
dence that integrins may also function as signal transducing 
molecules and mediate "outside to in" signaling. CD4 + T 
lymphocytes stimulated by anti-TCR antibodies in combi- 
nation with plate-bound FN or laminin demonstrate a marked 
augmentation of proliferation compared with stimulation by 
antibodies alone (19, 42, 43). The recent observations that 
certain mAbs to the/51 chain can increase integrin function 
(44, 45) also suggest that the binding of integrins  to their 
physiologic ligands upregulates receptor affinity and initiates 
a signal cascade. 
The expression of a4/51, ot6B1, and aLB2 by thymocytes 
suggests that these receptors may play a role in thymic T 
cell development. Early support for this hypothesis came from 
studies of avian embryonic thymuses (46) which demonstrated 
that the homing of hemopoietic tissue-derived precursors de- 
pended on an interaction between FN and a/51 chain-con- 
taining FN receptor defined by a polyclonal serum (47). Sub- 
sequently,  it  was  shown  that  murine CD4/CD8-double 
negative (DN) thymocytes expressed high levels of oe4/51 and 
used this receptor to bind to plate-bound FN or FN expressed 
on the surface ofa thymic stroma-derived cell clone (48, 49). 
Only a small percentage of the DP thymocytes (10-20%) 
demonstrated specific  adhesion to FN, a4/51 expression pro- 
gressively  decreased as cells became DP and was almost nega- 
tive on the CD4 and CD8 single positive (SP) cells. A crit- 
ical finding was that this adhesion by DNs appeared to be 
constitutive  as no activation was required  in the assays. If 
purified DNs were cultured on thymic stromal monolayers, 
a small percentage of the cells (1-3%) differentiated to be- 
come DP. This apparent in vitro differentiation could be in- 
hibited by addition of an anti-FN antibody, suggesting a link 
between the function of a FN receptor(s) and the differentia- 
tion of DN thymocytes. Similarly, a role for ctL/52 in thymo- 
cyte differentiation has been postulated based on the obser- 
vation that mitogen-activated human thymocytes could adhere 
to thymic epithelial cells and that the adhesion could be in- 
hibited by anti-ctL or anti-ICAM-1  antibodies (24). In con- 
trast to the constitutive  activation of ot4/51 on the murine 
DNs,  the o~L/52-mediated adhesion of unseparated human 
thymocytes required prior activation. 
Our understanding of thymocyte  development has largely 
been derived from murine model systems and has been greatly 
facilitated by the use of transgenic and knockout animals (7, 
50). However, a detailed investigation of the expression and 
function of integrins in murine T cell development has not 
been possible because of the lack of appropriate reagents. In 
this paper, we have analyzed both the expression and func- 
tion of tx4B1 and c~531 on human thymocytes. We demon- 
strate that human DP thymocytes express high levels of ot4/31 
and that a major portion (40-50%) of the DP cells exhibit 
constitutive  activation of c~4~1 as measured by adhesion to 
both FN and VCAM-1. The constitutively adherent (AD) 
DP thymocytes  expressed  higher levels  of  CD4/CD8 and lower 
levels of CD3 and CD69 compared with the nonadherent 
(NAD) DPs, which is consistent with the phenotype of less 
mature thymocytes. The NADs expressed similar levels of 
o~4/51, relatively lower levels of CD4/CDS, higher levels of 
CD3  and  CD69,  and  were also enriched  for  the CD4  hi 
CD8  int and CD4t~tCD8  hi "transition" cells that define the 
phenotype of DP thymocytes that have undergone or are in 
the process of undergoing positive selection (10, 11). Stimu- 
lation of the ADs with the combination of TCR cross-linking 
and plate-bound  FN failed to induce T  cell proliferation, 
whereas the NADs proliferated vigorously to this combina- 
tion.  Although the NADs continued to express high levels 
of ol431, their proliferative response was mediated predomi- 
nantly by ot5~1. In sum, our results demonstrate that a unique 
population of immature DP human thymocytes can be defined 
and separated by expression of an activated form of the/51 
integrin, cr4/51. These DP cells appear poised at a stage just 
before positive selection, a process that results in the loss of 
ot4/51 activity without significant change in its surface ex- 
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of CD3, CD4/CD8, and CD69. Models for the integration 
of these new findings into current paradigms for thymic T 
cell development will be discussed. 
Materials and Methods 
Antibodies.  The following antibodies were used: TS2/7 anti- 
txl/~l (T Cell Diagnostics,  Cambridge,  MA), Gi9 anti-o~2B1 (Amac, 
Inc., Westbrook, ME), P1B5 anti-c~3/31, PIB5 anti-ct3/31 (GIBCO 
BRL, Gaithersburg, MD), HP2/1  anti-or4/31 (Amac, Inc.), L25 
anti-c~4/31 (Becton Dickinson,  San Jose, CA),  PID6  anti-c~5/31 
(GIBCO BRL), SAM1 anti-or5/31 (Amac, Inc.), GoH3 anti-ct6/~l 
(Amac, Inc.), mAb16 anti-or5/31 and mAb13 anti-/31 (generous  gifts 
of Drs. K. Yamada  and S. Akiyama, National Institutes of Health), 
Leu 23 (L78) anti-CD69  (Becton Dickinson), OKT3 anti-CD3 
(American Type Culture Collection, [ATCC], Rockville, MD), 
13B8.2 anti-CD4 biotin or PE (Amac, Inc.), B9.11 FITC control 
(Amac, Inc.), mouse IgG1 and IgG2 isotype controls (Amac, Inc.), 
18.5 IgG2 isotype control (ATCC), and purified mouse IgG (Sigma 
Chemical Co., St. Louis, MO). 
Cytofluorometric Analysis.  Flow cytometry was performed on 
a FACScan  |  (Becton Dickinson) and analyzed with Lysis II soft- 
ware. Three-color  detection involved  FITC, PE, and Tricolor (Cahag 
Laboratories, South San Francisco, CA) excited at 488 nm. List 
mode data were collected on 4  x  104 cells and data is expressed 
as log mean fluorescence intensity (MFI). 
Freshly prepared thymocytes (106 cells/aliquot) in HBSS/3% 
FCS/0.1% NaAzide were incubated with 2 #g per tube of  purified 
mAb or 1:100 dilution of ascites for 45 min at 4~  Next, cells 
were incubated with 50 #1 per tube of a 1:300 dilution of PE-labeled 
goat F(ab')2 anti-mouse affinity-purified  antibody (Tago Immuno- 
logicals, Burlingame, CA). Unbound secondary  antibody sites were 
then blocked  by 20 #g per tube of  purified  mouse IgG (Sigma  Chem- 
ical Co.) for 20 min followed by addition of FITC-labeled mouse 
anti-human CD8 and biotin-conjugated mouse anti-human CD4 
(Amac, Inc.) for 45 min. The final step was addition of SA-Tricolor 
(Cahag Laboratories) for 30 rain. At least two isotype-matched 
control antibodies were used. Compensation and quadrant para- 
meters were set with both controls using PE-labeled anti-mouse 
as well as directly labeled FITC and biotin-conjugated control an- 
tibodies with SA-Tricolor. Nonviable cells were excluded by incu- 
bation with propidium iodide and by setting an additional gate 
at the extreme range of FL3. 
Cell Separation, Adhesion, and Proliferation.  Fresh  thymus frag- 
ments were obtained during cardiac surgery on children (aged 1 
mo to 3 yr) with congenital valvular malformations. Thymocytes 
were prepared by physical  disruption of  tissue over a 60-mesh stainless 
steel screen and separated by Ficoll-diatrizoate gradient (Organon 
Teknika, Durham, NC). Separation by adhesion was done with 
100  x  20 mm plates (Costar Corp., Cambridge, MA) coated by 
10 pg/ml of  purified human FN (Calbiochem-Novabiochem  Corp., 
La Jolla, CA) for 4 h at 37~  blocked with 1% heat denatured 
BSA, and then incubated with thymocytes in serum-free media 
(AIM-V, GIBCO BRL) for 1 h at 37~  After three washes the 
adherent cells were removed with gentle agitation  and EDTA 
(1:5,000 Versene, GIBCO BRL). Separation into CD4- and CD8- 
positive subsets was done by two rounds of  negative selection  with 
either anti-CD4 or anti-CD8 magnetic beads (Dynal, Inc., Great 
Neck, NY) to a purity of >98%  by flow cytometry. 
FN-adhesion assays  were performed in triplicate in 96-weU mi- 
crotiter plates (Dynatech Labs., Inc., Chantilly, VA) coated with 
human FN at 4~  overnight and blocked with 2.5% BSA (17). 
SlCr-labeled cells (5  x  10S/well) at 37~  were added in Medium 
199 (GIBCO BRL) with 0.5% BSA and incubated  for 1 h at 37~ 
Antibody blocking studies were done at 1-2 #g/ml ofmAb though 
antibody titrations from 0.1-10 #g/ml were also done with similar 
results (data not shown). Adhesion to rVCAM-1 was done in 48- 
well microtiter plates (Costar Corp.) coated overnight at 4~  with 
2.8 #g/ml purified rVCAM-1 (modified from reference 51). After 
blocking with 2.5% BSA, the SlCr-labeled cells were added and 
incubated for 30 min at 37~  Data for all adhesion assays  are ex- 
pressed as percent specific adhesion after subtraction of the BSA 
control. 
Cell proliferation assays  were performed in triplicate in 96-well 
microtiter plates (Costar Corp.) coated with anti-CD3 antibody 
overnight followed by FN for 4 h at 37~  Thymocytes at 2  x 
105 ceUs/weU were cultured in serum-free media for 4 d, pulsed 
with [3H]TdR (1/~Ci/well)  for the final 12 h, harvested  onto glass 
filter paper, and counted by liquid scintillation. In assays testing 
for mAb inhibition of proliferation, the plates were also blocked 
with 1% heat denatured BSA and the media was supplemented 
with 20/~g/ml of purified polyclonal mouse IgG to exclude any 
artifact from introduction of Ig protein to the cultures in serum- 
free media. For mitogen activation the combination of PMA (10 
ng/ml) and Ionomycin  (200 ng/ml) or PHA (5 #g/ml), alone, were 
added from serum-free stock solutions. 
Results 
Expression of  ~l Integrins on Human Thymocyte Subsets.  As 
an initial approach to determining a role for the/31 integrins 
during  thymocyte maturation,  we  used  three-color  flow 
cytometry to study the levels of expression of these integrins 
on the major thymocyte subsets  (Fig.  1).  c~1/31 and ol2/31 
were expressed at very low but consistently detectable levels 
by the DNs and SPs. The levels of expression of o~3/31, ol5~1, 
and c~6B1 were very similar and were higher on the SPs, par- 
ticularly the CD4 + cells, than on the DPs.  The very small 
DN population could be divided into two distinct popula- 
tions that were positive or negative for these three integrins. 
These results are not consistent with previous reports on 
human thymus in which the expression of c~3/31 and o~5B1 were 
described  as negligible and the levels of o~1B1 and ot2/31 
were not detectable (14-16). However, some of these studies 
were performed on frozen sections, cryopreserved thymocytes, 
or thymocytes that had been incubated in culture media over- 
night. When we analyzed frozen thawed thymocytes, we only 
detected o~4/$1 and ot6B1 at levels substantively lower than 
those expressed  on the fresh populations. 
Nonetheless, the integrin most prominently expressed on 
human thymocytes  was ot4B1; DPs expressed the highest level, 
whereas the CD8 SPs expressed <50% the level of that found 
on the DPs. The CD4 SPs demonstrated two distinct popu- 
lations. When gated separately, the majority population had 
an c~4/31 level similar to that of the CD8 SPs. The DN cells, 
comprising <3% of human thymocytes, could be divided into 
a o14fll negative subpopulation and a population that expressed 
a level of c~4fll similar to that of the SPs. About 3% of human 
thymocytes are "y/8 T cells, many of which will express the 
DN phenotype. We have determined that the expression  of 
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Figure  1.  Flow cytometry  of human thymo- 
cytes.  Three-color  flow  cytometry  on  human 
thymocytes consistently revealed the CD4/CD8 
profile depicted in the top frame (n  =  6). 2  x 
105 thymocytes were analyzed for each frame and 
gates were set after setting compensation first with 
a directly labeled FITC control  (FLI:  CD8),  a 
biotin-labeled control plus SA-Tricolor  (FL3: CD4) 
and three isotype-matched mouse antibody con- 
trols with anti-mouse PE-labeled antibody (FL2: 
integrin).  Histograms  represent  the  log  mean 
fluorescence  intensities  of  integrin  expression 
within the individual CD4/CD8 quadrants: DN, 
DP, CD4 SP, and CD8 SP. The anti-~4 antibody 
clone was HP2/1 and the anti-c~5 was SAM 1. 
o~4fll and ot531 by thymic "y/5 T cells is at least equivalent 
to the mature SP ot/3 thymocytes (data not shown). Thus, 
it is likely that the integrin-positive population of DNs is 
substantially comprised of 3'/5 T  cells. 
A Su~opulation of Thymocytes Demonstrates Constitutive  Adhe- 
sion to FN Mediated Predominantly by ot4fll.  The c~331 and 
ot6/31 integrins are receptors for the ECM protein, laminin, 
whereas c~3/31, o~431, and ot531 are receptors for FN as well 
as other ligands (13). These integrins on peripheral T lym- 
phocytes exist in a low affinity state and cell activation is re- 
quired to upregulate their affinity of binding (20,  42).  Be- 
cause of their  expression  on  the  majority of the human 
thymocytes, we next evaluated the capacity of human thymo- 
cytes to adhere to FN or laminin-coated plates. Surprisingly, 
approximately half of the thymocytes adhered to plate-bound 
FN in the absence of TCR-mediated or phorbol ester activa- 
tion (Fig. 2 A). The adherent thymocytes represented almost 
entirely DPs (only 2% SPs) with relatively high mean CD4 
and CD8 expression as compared with the NADs that were 
significantly enriched for the SPs and intermediate CD4/CD8- 
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Figure 2.  Thymocyte  adhesion  to FN and VCAM-1. 
Freshly prepared thymocytes were SlCr-labeled  and in- 
cubated on plates coated with either FN (A and C) 
or VCAM-1  (B) with or without addition  of the 
specified mAbs or peptides. (,4 and B) Thymocytes 
plated without any activation; (C) Thymocytes preac- 
tivated with PMA (10 ng/ml) for 30 min before plating. 
All FN and VCAM-1 plates were also blocked with 
2.5% BSA before the adhesion step. The background 
binding to plates coated only with BSA ('-7-10%) 
was subtracted and only percent specific adhesion is 
depicted here. (*) Values too low to graph. 
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sion has been from 45 to 55% in six similar experiments (ex- 
pressed as percent specific  adhesion).  Very low constitutive 
adhesion to laminin was observed ("~10%, data not shown). 
Adhesion was completely inhibited by the addition of either 
anti-ol4  or anti-~/1 (Fig.  2 A). The latter result excludes the 
possibility that  an alternative  c~4 receptor  such as c~4fl7  is 
involved (52). The addition of anti-~5 mAb (SAM 1 or MAB 
16) had no effect on constitutive adhesion nor did addition 
of anti-o~l,  2, or 3 mAbs (data not shown). The c~5B1 inte- 
grin recognizes an RGDS site contained in the cell-binding 
region of FN (53), whereas o~4~/1 utilizes an alternative CS-1 
peptide located in  the  heparin-binding  region  (18,  34,  43, 
54). Further evidence that o~4~1 was the predominant inte- 
grin mediating constitutive adhesion of human thymocytes 
to FN was obtained by demonstrating that soluble CS-1, but 
not RGD peptide, could inhibit constitutive adhesion (Fig. 
2 A).  RGE and a "scrambled"  sequence version (CS-ls)  of 
CS-1 served as negative peptide controls.  We also evaluated 
the binding of nonstimulated human thymocytes to VCAM-1. 
Approximately 40% of the human thymocytes demonstrated 
constitutive adhesion to purified recombinant VCAM-l-coated 
plates  (Fig.  2 B).  This  adhesion  was partially  inhibited by 
anti-~4 and completely by anti-ill mAbs. In contrast, ot4/31- 
mediated adhesion of peripheral blood T  cells to VCAM-1 
is  activation  dependent  (55). 
To determine the role of activation which is so critical in 
the adhesion of peripheral T cells, we repeated these experi- 
ments with PMA-activated thymocytes. Approximately 75- 
85 % of the thymocytes adhered to FN monolayers after acti- 
vation (Fig.  2 C) and the AD cells included the majority of 
SPs. Activation-dependent adhesion was inhibited by >50% 
by anti-c~4 (HP2/1) and  100% by anti-B1 mAbs. Whereas 
anti-c~5 mAb (SAM 1) had no effect alone, the combination 
of anti-c~5 and anti-c~4 mAbs completely inhibited adhesion. 
This  last  result  indicates  that  some  component  of PMA- 
activated adhesion is also mediated by oe531 in collaboration 
with oL4B1. The failure of the CS-1 peptide to inhibit  the 
activation-dependent adhesion (Fig. 2 C) is likely secondary 
to the involvement of cr  in the binding  or to the rela- 
tively poor ability of this reagent to inhibit c~431-mediated 
binding. Nonethdess, the much higher levels of oe431 receptor 
expression  as compared with  oe531  (Fig.  1 and  see Fig.  4) 
and the fact that  anti-oe5  alone had no inhibitory effect on 
adhesion of naive or PMA-activated ceils  suggests that  the 
predominant  FN receptor  on human  thymocytes is ot431. 
This is in contrast to the mature peripheral T  lymphocytes 
in  which  the  predominant  FN  receptor  is  an  activation- 
dependent  oe531. 
Constitutive Adhesion to FN Is a Property of a Subpopulation 
of Less Mature,  CD31~176  hi Thymocytes.  Our 
observation that  50% of thymocytes from multiple donors 
constitutively adhered to FN strongly suggested that  only 
a subpopulation of thymocytes was capable of adhesion.  There- 
fore, we separated thymocytes into AD and NAD popula- 
tions by constitutive adhesion to FN-coated plates and charac- 
terized  their  surface antigen phenotype (Fig.  3).  The  ADs 
were essentially all DP (97%, Fig. 3 A) with no enrichment 
for DNs as reported for murine thymocytes (48, 49). Although 
the NADs were also predominantly  DP (74%),  the NAD 
population was enriched for both SP CD4 and CD8 cells. 
More importantly, when the DP populations were compared 
by gating on the entire DP quadrant,  the mean levels of CD8 
and particularly  CD4 expression on the ADs were significantly 
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Figure  3.  CD4/CD8 expression 
by FN ADs and NADs. Unsepa- 
rated (UNS) thymocytes  and thy- 
mocytes separated by adhesion to 
FN-coated  plates  into AD and NAD 
subpopulations were analyzed by 
two-color flow  cytometry  (2 x  10  s 
cells/frame analyzed). (A) The rel- 
ative CD4  (PE:FL2) and  CD8 
(FITC:FL1) expression by  these 
populations  in log fluorescence  units 
where each dot represents one cell. 
MFIs for the CD4/CD8 DPs are 
shown in  the  upper right hand 
quadrants. The percentage of cells 
in each quadrant is shown for the 
CD4/CD8 DPs and for the CD4 
and CD8 SPs. (B) Only the up- 
per right hand quadrants of the 
ADs  and  NADs with  the  true 
CD4hiCD8hi DPs gated within the 
polygonal regions (Dphi). (C) The 
CD4 histograms for only the DP  hi 
regions: (shaded areas) ADs; (open 
areas) NADs. higher than on the NADs (see MFIs, Fig. 3 A). The lower 
mean levels of CD4 and CD8 expression by the DP NADs 
were, in part, secondary to an enrichment of DP transition 
cells which express intermediate levels of staining for either 
CD4 or CD8.  These CD4hiCD8 l~ and CD4m~  hi transi- 
tion cells resemble the "streak" cells recently described in class 
II-deficient transgenic mice as defining an intermediate level 
of maturation before mature SPs (11). The cell gates shown 
in Fig. 3 B were chosen to exclude the transition cells and 
determine the expression of either CD4 or CD8 by only the 
CD4hiCD8 hi  (DP  hi)  subpopulation.  These  results  are  ex- 
pressed as histograms in Fig. 3 C. It is striking that the MFI 
of CD4 is still lower on the DP  hi NADs (open area) as com- 
pared with the DP  hi ADs (shaded area)  whereas the levels 
of CD8 expression are equivalent. Thus, even the true DP  hi 
cells can be separated into two overlapping populations after 
adhesion to FN as defined by levels of CD4 expression. These 
results also suggest that CD4 expression may be more rap- 
idly downmodulated after positive selection which is sup- 
ported by the large CD41~  hi population evident in the 
DP NADs (Fig. 3 A). In this context it is interesting to note 
that developing human thymocytes have been reported to ex- 
press CD4 before CD8 in the transition  from DN to DP 
(56)  and  that  a  population  of  early  murine  thymocyte 
precursors  are also CD4 + (57). 
Additional evidence in favor of the hypothesis that consti- 
tutive adhesion to FN defines an early maturational  stage of 
DP thymocyte development was obtained by comparison of 
the levels of CD3 and CD69 on the DP FN ADs and NADs 
(Fig.  4).  In both murine and human models of thymocyte 
development, the increased expression of these two markers 
correlates with a more advanced developmental stage for DPs 
ADs  NADs 
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Figure 4.  Expression  of CD3, 
CD69, o~4~1 and ot5~/1 by DPs. 
Three-color flow cytometry on 
thymocytes  separated  by adhesion 
to FN-coated  plates into ADs (left) 
and NADs (right) was used to 
measure the expression of CD3 
(OKT3), CD69 (Leu 23), ot4/~1 
(HP2/1), and ot5/~1 (P1D6) (2 x 
10  s cells/frame  analyzed). Expres- 
sion is depicted in  the accom- 
panying histograms as log mean 
fluorescence (PE:FL2). Isotype- 
matched controls were  used  to es- 
tablish negative  gates and compen- 
sation. The DP thymocytes  were 
gated as depicted in the top two 
panels (ADs  and NADs). All DPs 
gated in  the upper right hand 
quadrants are shown in the histo- 
grams as the open area curves 
whereas the  subpopulation of 
CD4hiCDS~ DPs (DP  hl) gated by 
the polygonal regions are shown 
as the closed area curves. 
(8, 9).  The DP NADs expressed a higher number of cells 
with intermediate to high CD3 expression and CD69-positive 
cells than the DP ADs (Fig. 4, open areas).  Some of the in- 
crease in the levels of expression of CD3 and CD69 was cor- 
related with an increased percentage of the CD4hiCD8]~ and 
CD4]~  transition cells in the NAD population. How- 
ever, increased levels of CD3 and CD69 expression were also 
observed when  we gated  exclusively on  the  CD4hiCD8hi 
population (Fig.  4, shaded areas).  Thus, the DP population 
of maturing human thymocytes can be separated by the prop- 
erty of constitutive adhesion to FN and this separation corre- 
lates with maturation level by differential expression of CD3, 
CD69, CD4, and CD8. We also determined the surface pheno- 
type of the thymocytes separated by constitutive adhesion 
to plate-bound recombinant VCAM-1. Similar to the FN ADs 
and  NADs,  the  VCAM-1  ADs  were almost  all  DPs  and 
demonstrated fewer intermediate to high CD3- and CD69- 
positive cells as compared with the NADs (data not shown). 
One possible explanation for the separation of thymocytes 
into FN AD and NAD populations is a differential level of 
expression for ot4~/1. However, in multiple experiments, the 
DP FN ADs exhibited only a slightly higher level of expres- 
sion of ot4/31 when compared with the NADs. This was true 
whether the entire DP population was analyzed as depicted 
in Fig.  4  (open areas;  mean channel  128 vs.  109) or when 
only the DP  hi were gated (shaded areas;  mean channel  111 
vs. 83). Similarly,  the DP ADs and NADs expressed com- 
parable levels of o~5r  though the NADs were more heter- 
ogenous in expression. The expression of oe5B1 in Fig. 4 is 
somewhat less than that shown for the unseparated DPs in 
Fig. 1 but this was due to donor variation and a lower FL2 
channel gain setting in this experiment and not to any differ- 
ence in affinity of the anti-ot5~l antibodies used (e.g., SAM1 
vs. P1D6). It is consistent that the expression of c~4/~1 is also 
somewhat less, and these results were confirmed in multiple 
similar experiments.  The expression of the integrin  otL~/2 
(LFA-1) was  the  same  on  the  ADs  and  NADs  (data  not 
shown). 
Only FIX[  NADs Proliferate when Stimulated with Anti-CD3 
and FN.  Proliferation of peripheral blood T cells can be in- 
duced by relatively high concentrations of plate-bound anti- 
CD3 antibody or by suboptimal concentrations of anti-CD3 
if a costimulatory signal is provided by plate-bound ECM 
proteins  such as FN (19,  42, 43).  In contrast to peripheral 
blood T  cells, unseparated thymocytes or purified CD4 and 
CD8 SPs failed  to proliferate when stimulated with plate- 
bound anti-CD3  over a wide range of concentrations (data 
not shown).  However, when FN was coimmobilized with 
anti-CD3,  the unseparated and the purified CD4 and CD8 
SP populations demonstrated significant proliferative responses 
(Fig.  5 A). Moreover, the proliferative response of the CD4 
SP population to intact FN was much greater than that of 
the unseparated  thymocytes and the purified CD8 SPs. Prolifer- 
ation was dependent on concomitant TCR. cross-linking by 
anti-CD3 because plate-bound FN without anti-CD3 anti- 
body failed to induce proliferation  (data not  shown).  The 
addition of PMA did not supplant the requirement for TCR 
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nificantly increased thymocyte binding to FN including a 
population using the a5B1 receptor (Fig. 2 C). Flow cytom- 
etry of thymocytes activated by the combination of anti-CD3 
and FN was performed at initiation of culture and at 96 h. 
This demonstrated that the proliferating cells increased their 
CD3 and CD69  expression, increased  the relative  number 
of both CD4 and CD8 SPs, yet still demonstrated at least 
50% DPs, particularly of the intermediate CD4/CD8 subset 
(data not shown). Thus, the phenotype of the input popula- 
tion does change during the culture period which is consis- 
tent with the observations that the majority of proliferation 
can be attributed to the more mature SPs. 
The proliferative responses of all the subsets were markedly 
inhibited by the addition of anti-a5  (SAM  1 or MAB16), 
but  not by  anti-or4  mAb  (Fig.  5  B).  These  results were 
confirmed with separated CD4 and CD8 SPs. However, the 
confirmed with separated CD4 and CD8 SPs. However, the 
combination of both mAbs did result in higher inhibition 
at limiting concentrations of each antibody, suggesting that 
a4/~1 may supply some collaborative  signal for activation in 
concert with the critical cr5~l-derived signal.  Nonetheless, 
only the  RGDS-containing  120-kD  FN  fragment  (ot5~1 
specific), but not the CS-l-containing 40-kD fragment (ot4~l 
specific), could provide the costimulation required for mea- 
surable thymocyte  proliferation (Fig. 5 A). Thus, thymocyte 
proliferation to TCR cross-linking and FN is predominantly 
ot5~1  dependent. 
Thymocytes separated  on the basis of constitutive adhe- 
sion to FN were also tested for their ability to be stimulated 
by plate-bound anti-CD3 and FN (Fig. 6). The FN ADs failed 
to proliferate,  whereas the FN NADs showed an enhanced 
proliferative response relative to the unseparated cells. How- 
ever, both the FN ADs and NADs proliferated equally well 
when triggered with the combination of PMA and ionophore 
(Fig.  6).  Thus, although the ADs express  a constitutively 
functional form of ot4~l that can bind FN,  they have not 
reached the maturational stage of the NADs where they can 
be triggered via their TCR even in the presence  of FN as 
a costimulus. In contrast, the NADs which include all the 
SPs and do not demonstrate constitutive activation of ot4B1, 
do have the capability of TCR-mediated activation of their 
c~5B1 receptors,  such that these cells can proliferate  to the 
combination of plate-bound OKT3 and FN. 
Discussion 
We have identified a unique subset of immature DP human 
thymocytes  defined by their expression of a constitutively ac- 
tivated form of the B1 integrin, c~4B1, which mediates the 
binding of these cells to both FN and VCAM-1. This subset 
of DPs is characterized  by high levels of CD4 and CD8 ex- 
pression but low to intermediate levels of CD3 and CD69. 
In parallel,  we have described  a more mature population of 
Figure 5.  Proliferation  to plate-bound anti-CD3 and FN. (A) The 
proliferation  ([3H]TdR incorporation) of unseparated (UNS)  and purified 
CD4 + or CD8 + thymocytes  after a 72-h culture in plates coated with 
both anti-CD3 and intact  FN or the FN fragments; 120-kD (RGDS site) 
and 40-kD (CS-1 site). Cells  cultured  with anti-CD3 and no FN (No ECM 
line) gave  <10,000 cpm backgrounds.  The results are representative  of six 
similar experiments.  All proliferation  assays  were  performed  in serum-free 
media. (/3)  The dose  titrations  for antibody  blocking  of  unseparated  thymo- 
cytes proliferating  to anti-CD3 and FN, though similar  results for mAb 
inhibition  were also obtained  with purified  CD4 + and CD8 + cells. The 
mAb control was clone 18.5 (IgG2), anti-aS was SAM 1 (similar  results 
obtained with MAB 16) and anti-or4 was HP2/1. Proliferation  without 
any added mAb was ,-60,000 cpm. 
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Figure  6.  Proliferation  of FN ADs and NADs. UNS, AD, or NAD 
thymocytes  were cultured  in serum-free  media  for 72 h on plates coated 
with anti-CD3 and FN (FN) or with PMA/Ionomycin  (PMA/ION).  The 
proliferation of cells ([3H]TdR incorporation) in media, alone (data not 
shown), or with anti-CD3 and no FN (No ECM) was <1,000 cpm. (*) 
Values too low to graph. 
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oe431 without a significant change in its surface expression 
and that express lower levels of CD4 and/or CD8 and higher 
levels of CD3 and CD69. In addition, we have demonstrated 
that the FN NAD population which contains SP thymocytes 
has acquired the ability to proliferate to TCR cross-linking, 
but only if a costimulatory signal is provided by plate-bound 
FN  or  the  RGDS-containing  120-kD  fragment  of FN. 
Costimulation is mediated primarily by a second FN receptor, 
cr  These studies demonstrate that integrin expression and 
function mark specific stages in human thymocyte develop- 
ment and suggest a direct involvement of regulated integrin 
function in thymic T  cell development. 
Our results appear to be markedly different from those 
previously reported for both the expression and function of 
oe4~1 on murine thymocytes (48, 49). The expression of a431 
decreased significantly as murine thymocytes progressed from 
the DN to the DP stage and constitutive binding of murine 
thymocytes  to FN was primarily, but not exclusively, a prop- 
erty of DN thymic precursors.  Thus, it appeared that the 
high absolute levels of oe431 expression  on DN routine thymo- 
cytes determined their ability to adhere to FN. However, it 
is difficult to directly compare these results with our studies 
as the differential expressions of oe431, CD4, CD8,  CD3, 
and CD69 were not examined for the murine DP cells ad- 
herent and nonadherent to FN. It does appear that the majority 
of DN murine thymocytes express a431 in a constitutively 
active state and that a similar population of ceUs is not present 
in human thymus. Thus, activation of oe4fll may also be im- 
portant in the differentiation of murine thymocytes, but its 
role may be restricted to an earlier stage of thymocyte  devel- 
opment. 
A relationship between the constitutive function of an inte- 
grin receptor and maturation stage has been previously ob- 
served in both lymphoid (58) and nonlymphoid cells (59). 
For example, human peripheral blood B lymphocytes resemble 
peripheral T lymphocytes in that they express high levels of 
c~431, but are unable to bind to the CS-1 site in FN unless 
activated (60). In contrast, human bone marrow-derived B 
cell  precursors  demonstrated oe4fll-mediated  constitutive 
binding to VCAM-1 on the surface of  bone marrow-derived 
fibroblasts (61). Similarly, early CFU spleen cells obtained 
from mice expressed o14f11 and could be separated from bone 
marrow cell mixtures by constitutive adherence to the CS-1 
peptide site of FN (62). Pretreatment of bone marrow cells 
with anti-c~431 antibodies blocked subsequent colony for- 
mation in the spleen as well as medullary  hematopoiesis. Simi- 
larly, anti-or431 has been shown to block lymphopoiesis and 
to retard myelopoiesis in long-term cultures of mouse bone 
marrow (63). Collectively, these studies provide strong evi- 
dence for the presence of constitutively active c~431 on a stem 
cell population of the B lineage in both human and murine 
bone marrow. 
Our observations on the developmental regulation of cr 
on human thymocytes in many respects resembles the type 
of regulation reported for several different B1 integrins (oe2, 
oL3, and ce5B1) on human keratinoeytes (59, 64). Terminal 
differentiation of keratinocytes in culture is accompanied by 
a loss of adhesiveness  to several  ECM proteins including type 
IV collagen and FN (64). More importantly, the downmodu- 
lation of oe5~l-mediated  adhesion to FN can be separated 
into an initial stage when the receptor loses its ability to bind 
to FN and a second stage at which the receptor is lost from 
the cell surface (40). Although the absolute level of ~1 inte- 
grin expression correlates well with later stages of keratino- 
cyte differentiation,  the early transition  from stem cells to 
"transit amplifying cells," is accompanied by the same modest 
decrease in/31 integrin expression (59, 65), but absolute loss 
in function, that we have observed in the human DP thymo- 
cyte population  for oe431. A major difference between the 
differentiation of skin cells and thymocytes appears to be that 
the loss of integrin function is followed by a complete loss 
of 31 integrin expression during terminal differentiation of 
keratinocytes whereas there is only a modest decrease in ex- 
pression of ol431 and a parallel increase in expression of ol5fll 
in mature SP thymocytes. 
The oe4fll integrin recognizes distinct binding sites on FN 
and VCAM-1 (21, 22) and, under suboptimal conditions for 
adhesion  the binding  of ot4fll  to  the CS-1 peptide  and 
VCAM-1, may be differentially regulated (66). VCAM-1 is 
expressed by cytokine-activated endothelial cells (67, 68) and 
is an important determinant of leukocyte adhesion and func- 
tion during inflammation.  Therefore, the adherence of DP 
thymocytes to VCAM-1  may have important implications 
for thymocyte  development. VCAM-1 is expressed on some 
nonendothelial  stromal elements in the bone marrow (69), 
and thus it is possible that VCAM-1 expressed on stromal 
or epithelial elements in the thymus may be the true ligand 
for a431 on thymocytes. An activation-dependent  upregu- 
lation of VCAM-1 on thymic endothelium or epithelium may 
occur and involve cytokine production which has been de- 
scribed in certain thymic epithelial cultures (70).  VCAM-1 
has been found on dendritic cells in the germinal centers of 
lymph nodes (71). It is possible that VCAM-1 is expressed 
on dendritic cells in the thymus and may therefore play a 
role in the signaling events involved in negative selection. 
In addition to the role of oe4fll in mediating the adhesion 
of the less mature DP thymocytes, it should be emphasized 
that the induction of a proliferative response in the more ma- 
ture FN NAD population was completely dependent on a 
costimulatory signal mediated via c~531. Furthermore, in con- 
trast  to peripheral blood T  cells which can be induced to 
proliferate by stimulation with high concentrations  of im- 
mobilized anti-CD3, even the most mature SP thymocytes 
required costimulation by plate-bound FN at all concentra- 
tions of anti-CD3. Thus, o~5fll may play a critical role in 
T cell differentiation by regulating the proliferative expan- 
sion of certain maturing thymocyte clones. In contrast,  the 
major function of ot431 appears to be the regulation of cel- 
lular  tra~c for the immature DPs. 
How can we integrate these new observations with human 
thymocytes into the current paradigms of thymocyte devel- 
opment that have derived from murine models? The objec- 
tive of thymocyte maturation is the development of a stable 
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in the context of self-MHC restricting elements. Although 
we have not as yet directly proven that the FN-ADs differen- 
tiate into FN-NAD, we propose that differential regulation 
of the expression and function of oe431 and ct531 provides 
a mechanism by which thymocytes move from the cortex to 
the medulla and interact with both thymic epithelium and 
bone marrow-derived APCs, presumably at distinct sites and 
stages of maturation.  Our results are most consistent with 
the possibility that  ct431-mediated  adhesion of the imma- 
ture DPs to FN and/or VCAM-1 expressed on thymic epi- 
thelial surfaces or to ECM in close proximity facilitates  posi- 
tive selection. Successful positive selection is followed by a 
substantial increase in TCR/CD3 and CD69 expression with 
a parallel reduction in either CD4 or CD8 expression. These 
DP intermediate  or transition  cells are enriched in the FN 
NAD population and are the precursors of the mature SPs. 
Loss of constitutive oe431 activity after positive selection would 
allow the maturing DPs to move into the medulla where en- 
gagement with marrow-derived APCs or medullary epithe- 
lium may occur. Upregulation of TCR/CD3 expression by 
these maturing  cells also marks the capacity to respond to 
TCR  cross-linking  with  proliferation  if costimulation  is 
provided by FN via o~531 facilitating the clonal expansion 
of mature thymocytes after negative selection in preparation 
for their  transport  to the periphery. 
We have used the term "constitutive" to describe the acti- 
vated phenotype of oe431 and to reflect the experimental ob- 
servation that the immature DP population demonstrates adhe- 
sion to plate-bound FN or VCAM-1 without any activation 
step. We can suggest two models to explain this constitutive 
activity and its significance in thymocyte maturation  (Fig. 
7). It is possible that immature thymocytes during matura- 
tion from the DN to the DP stage express a constitutively 
activated form of oe431 because they do not possess the regula- 
tory elements in the cell membrane or cytoplasm (28,  72, 
73) necessary to inhibit the activated conformation (Fig.  7, 
MODEL I). The binding of c~431 would facilitate the inter- 
action of the TCR with its ligand, presumably.expressed on 
the surface of cortical epithelium, and lead to positive selec- 
tion and the upregulation of TCR/CD3 and CD69 expres- 
sion. Successful positive selection would be followed by a signal 
to deactivate the integrin and allow the maturing T  cell to 
disengage from the cortical epithelium.  If positive selection 
was unsuccessful the cell would remain fixed in the cortex 
by ol4/31 and apoptose. Alternatively,  the earliest DP precursors 
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Figure  7.  Two models for the role of a4/~1 in positive selection. (Model I) The early DP thymocytes  express a constitutively active form of oe4B1 
and use this integrin to bind FN expressed on or near the surface of cortical epithelium.  By stable adhesion to FN the a4/~1 facilitates the interaction 
of the few TCKs expressed with MHC/ligand. If successful positive selection occurs, the tx4~l receptor  switches to the inactive form and the cell 
detaches as a more mature TCR.hiCD69  inchi DP cell prepared  for migration and/or negative  selection. (Model I1) The early DP thymocytes  express 
an inactive form of oe4B1. A positive interaction  between the TCR and MHC/ligand on the cortical  epithelium permits activation  of c~431 but is 
insufficient to allow full cell activation.  The activated ol4/~1 stabilizes the DP cell on the cortical epithelium permitting full activation and completing 
the positive selection stage. Again, after full activation,  the a4jS1 receptor changes to the inactive form and the cell detaches to permit the next stage 
in maturation. 
1581  Salomon  et al. may express c~4~1 in the inactive state similar to PBLs (Fig. 
7, MODEL 11). DP cells whose TCR had sufficient affinity 
to bind to self-MHC for positive selection would use a pre- 
liminary  but unstable encounter to activate ot4B1 in a manner 
analogous to the TCR-mediated activation of  mature periph- 
eral T  cells. Activation of ot4fll would then permit a stable 
interaction with self-MHC on the epithelial surface and allow 
the maturing thymocyte to receive the microenvironment- 
derived signals required to complete positive selection. Failure 
to activate ol4~1 by positive selection would prevent delivery 
of these maturation signals and the cell would apoptose. Com- 
pletion  of maturation would be  marked by increases in 
TCR/CD3  and CD69 expression and the subsequent loss 
of ot4B1 activity would be consistent with the transient na- 
ture of integrin receptor activation described in several model 
systems (13, 17). This model would account for the presence 
of some immature DP TCK/CD3  l~ cells in the FN NAD 
population whose TCR lacked sufficient affinity for positive 
selection and which were therefore destined to die. 
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